Author:
Kerwin Edward,Wachtel Andrew,Sher Lawrence,Nyberg Jack,Darken Patrick,Siddiqui Shahid,Duncan Elizabeth A.,Reisner Colin,Dorinsky Paul
Funder
Pearl – a member of the AstraZeneca Group
AstraZeneca, Cambridge, UK in accordance with Good Publication Practice (GPP3) guidelines
Subject
Pulmonary and Respiratory Medicine
Reference37 articles.
1. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
2. 2017 GINA Report, Global Strategy for Asthma Management and Prevention;Global Initiative for Asthma,2017
3. European Medicines Agency, Guideline on the Clinical Investigation of Medicinal Products for the Treatment of Asthma,2015
4. Positioning of long-acting muscarinic antagonists in the management of asthma;Aalbers;Allergy Asthma Immunol. Res.,2017
5. Asthma control and management in 8,000 european patients: the REcognise asthma and LInk to symptoms and experience (REALISE) survey;Price;NPJ. Prim. Care Respir. Med.,2014
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献